View Older Stories

Jun 18, 2026 05:47AM Oral Wegovy reaches 33% of total prescriptions by May

Jun 17, 2026 03:58PM Hims and Hers (HIMS) PT Raised to $39 at Barclays, 'Our Proprietary Data Points to Sharp Inflection'

Jun 16, 2026 06:22AM Leerink on Hims and Hers (HIMS): 'We still think the stock will be more driven by the puts and takes of near-term GLP-1 profitability'

Jun 3, 2026 07:05AM Canaccord Reiterates Buy Rating on Hims and Hers (HIMS)

Jun 2, 2026 08:19AM Leerink Reiterates Market Perform Rating on Hims and Hers (HIMS)

May 28, 2026 12:02PM HIMS adds eight wellness partners to subscriber benefits program

May 26, 2026 05:14PM Hims & Hers Health, Inc. (HIMS) Spikes 2.8% as Board of Directors David Wells Buys $1.1mn Worth of Stock

May 26, 2026 05:25AM Hims and Hers (HIMS) PT Lowered to $25 at BofA Securities

May 22, 2026 05:42AM Hims and Hers (HIMS) PT Raised to $23 at Truist Securities

May 21, 2026 09:01AM Hims & Hers launches generic semaglutide in Canada at $149 monthly

May 21, 2026 09:00AM Hims & Hers launches generic semaglutide in Canada at $149 monthly

May 18, 2026 09:04AM Hims and Hers (HIMS) PT Lowered to $28 at BofA Securities

May 12, 2026 10:41AM Hims and Hers (HIMS) PT Lowered to $24.50 at Jefferies, 'execution story now'

May 12, 2026 09:10AM Hims and Hers (HIMS) PT Lowered to $30 at BofA Securities

May 12, 2026 07:56AM Hims & Hers stock tumbles as revenue, EBITDA miss estimates

May 12, 2026 07:51AM BTIG on Hims and Hers (HIMS): 'will need to aggressively manage sales and marketing costs'

May 12, 2026 07:27AM Hims and Hers (HIMS) PT Raised to $25 at TD Cowen

May 12, 2026 07:13AM Hims and Hers (HIMS) PT Raised to $35 at Needham

May 12, 2026 06:20AM Hims and Hers (HIMS) PT Raised to $35 at Needham

May 12, 2026 05:22AM Hims and Hers (HIMS) PT Raised to $28 at Citi

May 12, 2026 05:19AM Evercore ISI on Hims and Hers (HIMS): 'Prognosis Unclear'

May 12, 2026 05:11AM Hims and Hers (HIMS) PT Raised to $32 at Canaccord

May 11, 2026 04:06PM Hims & Hers Health, Inc. (HIMS) Misses Q1 EPS by 41c, Misses on Revenue; Offers FY26 Revenue Guidance

May 11, 2026 12:00PM Hims & Hers earnings preview: BofA says company lost GLP-1 share in 1Q

May 11, 2026 10:49AM Hims & Hers Health, Inc. (HIMS) call put ratio 3.4 calls to 1 put with a focus on 1K contracts of January 105 calls into quarter results

May 11, 2026 09:39AM Truist on Hims and Hers (HIMS): 'NVO Partnership Off to a Solid Start'

May 8, 2026 10:54AM Hims & Hers Health, Inc. (HIMS) spreader of May calls into quarter results

May 8, 2026 04:54AM Hims & Hers Health, Inc. (HIMS) spreader of 2K contracts of May 28 and 30 calls into quarter results

May 7, 2026 07:04AM Amazon Pharmacy adds same-day delivery for Ozempic pill

Apr 24, 2026 02:15AM JPMorgan Starts Hims and Hers (HIMS) at Overweight

Apr 23, 2026 09:49AM Hims and Hers (HIMS) PT Raised to $32 at BofA Securities

Apr 23, 2026 08:40AM Hims & Hers expands platform to include Eli Lilly weight loss medications

Apr 21, 2026 01:33PM Morgan Stanley Comments Eli Lilly (LLY) and Medicare GLP-1 Obesity Coverage

Apr 21, 2026 09:10AM Amazon One Medical launches weight management program with GLP-1 drugs

Apr 21, 2026 09:09AM Hims & Hers Extends Drop To 6% After Amazon Glp-1 News

Apr 16, 2026 11:31AM FDA encourages testosterone therapy makers to seek low libido indication

Apr 16, 2026 11:11AM Leerink Partners on Hims and Hers (HIMS): FDA meeting to discuss peptide restrictions 'clear positive,' could fill growth hole

Apr 15, 2026 05:06PM Hims and Hers (HIMS) PT Raised to $25 at BofA Securities

Apr 15, 2026 02:16PM Hims & Hers Health, Inc. (HIMS) Strength Tied to RFK Jr Comments on Peptides

Apr 8, 2026 05:11AM Hims and Hers (HIMS) PT Lowered to $21 at BofA Securities

Mar 31, 2026 06:35AM Wolfe: 'We're observing some reports of GLP-1 users refreshing their wardrobes as weight loss progresses'

Mar 27, 2026 09:20AM Hims and Hers (HIMS) PT Lowered to $23 at TD Cowen

Mar 27, 2026 05:12AM Canaccord on Hims and Hers (HIMS): 'Novo partnership goes live; near-term headwind to revenue, long-term tailwind to the story'

Mar 26, 2026 01:17PM BofA on Hims and Hers (HIMS): '$149/month subscription fee is slightly higher than we initially expected'

Mar 26, 2026 12:00PM HIMS partners with Novo Nordisk to offer FDA-approved GLP-1 medications

Mar 18, 2026 08:55AM HIMS to offer Wegovy and Ozempic through partnership with Novo Nordisk

Mar 16, 2026 06:16AM Street Calls of the Week

Mar 13, 2026 10:09AM Hims shares set for best week on record after new Novo Nordisk deal

Mar 10, 2026 08:10PM Hims & Hers hires ex-Eli Lilly PR chief Beiser as top communications officer

Mar 10, 2026 06:10AM BofA Securities Upgrades Hims and Hers (HIMS) to Neutral

View Older Stories